test_cases:
  # ========================================
  # SMALL MOLECULE KINASE INHIBITORS
  # ========================================
  - id: "imatinib_targets_001"
    tool: "search_drug_targets"
    input:
      drug_name: "imatinib"
    expected_facts:
      required:
        - "ABL1 is a target of imatinib"
        - "KIT is a target of imatinib"
        - "PDGFRA is a target of imatinib"
      optional:
        - "imatinib has ChEMBL ID CHEMBL941"
        - "PDGFRB is a target of imatinib"
    source: "ChEMBL"
    confidence: "high"

  - id: "erlotinib_targets_002"
    tool: "search_drug_targets"
    input:
      drug_name: "erlotinib"
    expected_facts:
      required:
        - "EGFR is a target of erlotinib"
      optional:
        - "erlotinib is an EGFR inhibitor"
        - "erlotinib is used for lung cancer"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "ruxolitinib_targets_003"
    tool: "search_drug_targets"
    input:
      drug_name: "ruxolitinib"
    expected_facts:
      required:
        - "JAK1 is a target of ruxolitinib"
        - "JAK2 is a target of ruxolitinib"
      optional:
        - "ruxolitinib is a JAK inhibitor"
        - "ruxolitinib is used for myelofibrosis"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "vemurafenib_targets_004"
    tool: "search_drug_targets"
    input:
      drug_name: "vemurafenib"
    expected_facts:
      required:
        - "BRAF is a target of vemurafenib"
      optional:
        - "vemurafenib targets BRAF V600E mutation"
        - "vemurafenib is used for melanoma"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "palbociclib_targets_005"
    tool: "search_drug_targets"
    input:
      drug_name: "palbociclib"
    expected_facts:
      required:
        - "CDK4 is a target of palbociclib"
        - "CDK6 is a target of palbociclib"
      optional:
        - "palbociclib is a CDK4/6 inhibitor"
        - "palbociclib is used for breast cancer"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  # ========================================
  # COX INHIBITORS / NSAIDs
  # ========================================
  - id: "aspirin_targets_006"
    tool: "search_drug_targets"
    input:
      drug_name: "aspirin"
    expected_facts:
      required:
        - "PTGS1 (COX-1) is a target of aspirin"
        - "PTGS2 (COX-2) is a target of aspirin"
      optional:
        - "aspirin inhibits cyclooxygenase enzymes"
        - "aspirin is used for pain and inflammation"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "celecoxib_targets_007"
    tool: "search_drug_targets"
    input:
      drug_name: "celecoxib"
    expected_facts:
      required:
        - "PTGS2 (COX-2) is a target of celecoxib"
      optional:
        - "celecoxib is a selective COX-2 inhibitor"
        - "celecoxib is used for arthritis"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  # ========================================
  # BIOLOGICS / MONOCLONAL ANTIBODIES
  # ========================================
  - id: "pembrolizumab_targets_008"
    tool: "search_drug_targets"
    input:
      drug_name: "pembrolizumab"
    expected_facts:
      required:
        - "PDCD1 (PD-1) is a target of pembrolizumab"
      optional:
        - "pembrolizumab is a monoclonal antibody"
        - "pembrolizumab is an immune checkpoint inhibitor"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "trastuzumab_targets_009"
    tool: "search_drug_targets"
    input:
      drug_name: "trastuzumab"
    expected_facts:
      required:
        - "ERBB2 (HER2) is a target of trastuzumab"
      optional:
        - "trastuzumab is a monoclonal antibody"
        - "trastuzumab is used for HER2-positive breast cancer"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "nivolumab_targets_010"
    tool: "search_drug_targets"
    input:
      drug_name: "nivolumab"
    expected_facts:
      required:
        - "PDCD1 (PD-1) is a target of nivolumab"
      optional:
        - "nivolumab is a monoclonal antibody"
        - "nivolumab is used for melanoma"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "rituximab_targets_011"
    tool: "search_drug_targets"
    input:
      drug_name: "rituximab"
    expected_facts:
      required:
        - "MS4A1 (CD20) is a target of rituximab"
      optional:
        - "rituximab is a monoclonal antibody"
        - "rituximab is used for lymphoma"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "adalimumab_targets_012"
    tool: "search_drug_targets"
    input:
      drug_name: "adalimumab"
    expected_facts:
      required:
        - "TNF is a target of adalimumab"
      optional:
        - "adalimumab is a TNF-alpha inhibitor"
        - "adalimumab is used for rheumatoid arthritis"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  # ========================================
  # STATINS
  # ========================================
  - id: "atorvastatin_targets_013"
    tool: "search_drug_targets"
    input:
      drug_name: "atorvastatin"
    expected_facts:
      required:
        - "HMGCR is a target of atorvastatin"
      optional:
        - "atorvastatin is an HMG-CoA reductase inhibitor"
        - "atorvastatin is used to lower cholesterol"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  # ========================================
  # DIABETES DRUGS
  # ========================================
  - id: "metformin_targets_014"
    tool: "search_drug_targets"
    input:
      drug_name: "metformin"
    expected_facts:
      required:
        - "metformin has known pharmacological activity"
      optional:
        - "PRKAB1 is associated with metformin mechanism"
        - "metformin activates AMPK"
        - "metformin is used for type 2 diabetes"
    source: "ChEMBL/DrugCentral"
    confidence: "medium"

  # ========================================
  # TARGET â†’ DRUGS (Reverse Lookup)
  # ========================================
  - id: "egfr_target_drugs_015"
    tool: "search_target_drugs"
    input:
      gene_symbol: "EGFR"
    expected_facts:
      required:
        - "Drugs targeting EGFR are returned"
      optional:
        - "erlotinib is an EGFR inhibitor"
        - "gefitinib is an EGFR inhibitor"
        - "osimertinib is an EGFR inhibitor"
        - "afatinib is an EGFR inhibitor"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "abl1_target_drugs_016"
    tool: "search_target_drugs"
    input:
      gene_symbol: "ABL1"
    expected_facts:
      required:
        - "Drugs targeting ABL1 are returned"
      optional:
        - "imatinib is an ABL1 inhibitor"
        - "dasatinib is an ABL1 inhibitor"
        - "nilotinib is an ABL1 inhibitor"
        - "bosutinib is an ABL1 inhibitor"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "jak2_target_drugs_017"
    tool: "search_target_drugs"
    input:
      gene_symbol: "JAK2"
    expected_facts:
      required:
        - "Drugs targeting JAK2 are returned"
      optional:
        - "ruxolitinib is a JAK2 inhibitor"
        - "fedratinib is a JAK2 inhibitor"
        - "baricitinib is a JAK inhibitor"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "braf_target_drugs_018"
    tool: "search_target_drugs"
    input:
      gene_symbol: "BRAF"
    expected_facts:
      required:
        - "Drugs targeting BRAF are returned"
      optional:
        - "vemurafenib is a BRAF inhibitor"
        - "dabrafenib is a BRAF inhibitor"
        - "encorafenib is a BRAF inhibitor"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "alk_target_drugs_019"
    tool: "search_target_drugs"
    input:
      gene_symbol: "ALK"
    expected_facts:
      required:
        - "Drugs targeting ALK are returned"
      optional:
        - "crizotinib is an ALK inhibitor"
        - "alectinib is an ALK inhibitor"
        - "lorlatinib is an ALK inhibitor"
        - "ceritinib is an ALK inhibitor"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "cdk4_target_drugs_020"
    tool: "search_target_drugs"
    input:
      gene_symbol: "CDK4"
    expected_facts:
      required:
        - "Drugs targeting CDK4 are returned"
      optional:
        - "palbociclib is a CDK4/6 inhibitor"
        - "ribociclib is a CDK4/6 inhibitor"
        - "abemaciclib is a CDK4/6 inhibitor"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "vegfr2_target_drugs_021"
    tool: "search_target_drugs"
    input:
      gene_symbol: "KDR"
    expected_facts:
      required:
        - "Drugs targeting KDR/VEGFR2 are returned"
      optional:
        - "sunitinib is a VEGFR inhibitor"
        - "sorafenib is a VEGFR inhibitor"
        - "axitinib is a VEGFR inhibitor"
        - "pazopanib is a VEGFR inhibitor"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "met_target_drugs_022"
    tool: "search_target_drugs"
    input:
      gene_symbol: "MET"
    expected_facts:
      required:
        - "Drugs targeting MET are returned"
      optional:
        - "capmatinib is a MET inhibitor"
        - "tepotinib is a MET inhibitor"
        - "crizotinib has MET activity"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "mtor_target_drugs_023"
    tool: "search_target_drugs"
    input:
      gene_symbol: "MTOR"
    expected_facts:
      required:
        - "Drugs targeting MTOR are returned"
      optional:
        - "everolimus is an MTOR inhibitor"
        - "temsirolimus is an MTOR inhibitor"
        - "sirolimus/rapamycin is an MTOR inhibitor"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "ros1_target_drugs_024"
    tool: "search_target_drugs"
    input:
      gene_symbol: "ROS1"
    expected_facts:
      required:
        - "Drugs targeting ROS1 are returned"
      optional:
        - "crizotinib is a ROS1 inhibitor"
        - "entrectinib is a ROS1 inhibitor"
        - "lorlatinib is a ROS1 inhibitor"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  # ========================================
  # ADDITIONAL WELL-KNOWN DRUG-TARGET PAIRS
  # ========================================
  - id: "osimertinib_targets_025"
    tool: "search_drug_targets"
    input:
      drug_name: "osimertinib"
    expected_facts:
      required:
        - "EGFR is a target of osimertinib"
      optional:
        - "osimertinib targets EGFR T790M mutation"
        - "osimertinib is a third-generation EGFR TKI"
        - "AstraZeneca's Tagrisso"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "crizotinib_targets_026"
    tool: "search_drug_targets"
    input:
      drug_name: "crizotinib"
    expected_facts:
      required:
        - "ALK is a target of crizotinib"
        - "MET is a target of crizotinib"
      optional:
        - "ROS1 is a target of crizotinib"
        - "Pfizer's Xalkori"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "alectinib_targets_027"
    tool: "search_drug_targets"
    input:
      drug_name: "alectinib"
    expected_facts:
      required:
        - "ALK is a target of alectinib"
      optional:
        - "alectinib is a second-generation ALK inhibitor"
        - "Roche's Alecensa"
        - "alectinib is used for ALK-positive NSCLC"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "dabrafenib_targets_028"
    tool: "search_drug_targets"
    input:
      drug_name: "dabrafenib"
    expected_facts:
      required:
        - "BRAF is a target of dabrafenib"
      optional:
        - "dabrafenib targets BRAF V600E"
        - "dabrafenib is used for melanoma"
        - "Novartis/GSK Tafinlar"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "trametinib_targets_029"
    tool: "search_drug_targets"
    input:
      drug_name: "trametinib"
    expected_facts:
      required:
        - "MAP2K1 (MEK1) is a target of trametinib"
      optional:
        - "MAP2K2 (MEK2) is a target"
        - "trametinib is a MEK inhibitor"
        - "Often combined with dabrafenib for BRAF-mutant melanoma"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  - id: "larotrectinib_targets_030"
    tool: "search_drug_targets"
    input:
      drug_name: "larotrectinib"
    expected_facts:
      required:
        - "NTRK1 is a target of larotrectinib"
      optional:
        - "NTRK2 is a target"
        - "NTRK3 is a target"
        - "larotrectinib is a TRK inhibitor"
        - "Bayer's Vitrakvi"
    source: "ChEMBL/DrugCentral"
    confidence: "high"

  # ========================================
  # CONSOLIDATED PHARMACOLOGY SEARCH
  # ========================================
  - id: "imatinib_indications_101"
    tool: "pharmacology_search"
    input:
      search_type: "drug_indications"
      drug_name: "imatinib"
    expected_facts:
      required:
        - "imatinib is indicated for chronic myeloid leukemia"
      optional:
        - "imatinib is indicated for gastrointestinal stromal tumor"
    source: "DrugCentral"
    confidence: "medium"

  - id: "egfr_pathways_102"
    tool: "pharmacology_search"
    input:
      search_type: "target_pathways"
      gene_symbol: "EGFR"
    expected_facts:
      required:
        - "EGFR is associated with a signaling pathway"
      optional:
        - "EGFR is in MAPK pathway"
    source: "DrugCentral/Pathway"
    confidence: "medium"

  - id: "warfarin_interactions_103"
    tool: "pharmacology_search"
    input:
      search_type: "drug_interactions"
      drug_name: "warfarin"
    expected_facts:
      required:
        - "warfarin has drug interactions"
      optional:
        - "interaction includes bleeding risk"
    source: "DrugCentral"
    confidence: "low"
